"Kirk is a special leader, versed in both strategy and operational excellence. He understands the complexities of the healthcare landscape — and our customers’ needs — inside and out. He’s incredibly patient-focused and a terrific people leader"
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that Kirk Kaminsky will
be the new president of McKesson’s U.S. Pharmaceutical and Specialty
Solutions (USPSS) business. Kaminsky will assume the role effective
immediately, reporting to CEO Brian Tyler.
Kaminsky currently serves as president of McKesson Specialty Provider
Organization, a division of USPSS, where he leads a team responsible for
a broad suite of provider solutions. These include drug purchasing,
clinical and operational software and analytics, practice management
services and clinical trials across the McKesson Specialty Provider
base, including The
US Oncology Network.
“Kirk is a special leader, versed in both strategy and operational
excellence. He understands the complexities of the healthcare landscape
— and our customers’ needs — inside and out. He’s incredibly
patient-focused and a terrific people leader,” said Tyler. “His vision,
experience and leadership will help us continue to serve our customers
and business partners while expanding our service offerings and market
Kaminsky has been a McKesson executive since 2003, when he joined the
company’s Corporate Strategy and Business Development group. Since then,
he ran the U.S. Pharmaceutical packaging business and has been integral
to the company’s growing presence in the oncology space. He served as
president of The US Oncology Network and was responsible for its
financial and operational support; he also led the overall strategy in
support of The Network’s vision of improving patient outcomes and
quality of life, and advancing the future of cancer treatment by taking
a leadership role in value-based care.
“I’m very excited about this opportunity,” Kaminsky said. “McKesson’s
set of strategic assets positions us well to drive meaningful value
across the healthcare ecosystem. I’m also humbled and honored to lead
this team. This team of professionals is dedicated to operational
excellence, working with integrity and accountability and meeting our
Prior to McKesson, Kaminsky was with Bank One Corporation, where he was
responsible for setting and executing payment strategies across the
commercial and retail bank. He also spent a few years in investment
banking as a financial analyst, concentrating on corporate finance for
healthcare and consumer retail.
Kaminsky received an MBA from The Wharton School and a BA in Economics
for Business from Occidental College.
About McKesson Corporation
McKesson Corporation, currently ranked 6th on the FORTUNE
500, is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and healthcare
information technology. McKesson partners with pharmaceutical
manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical
products and healthcare services to the right patients at the right
time, safely and cost-effectively. United by our ICARE shared
principles, our employees work every day to innovate and deliver
opportunities that make our customers and partners more successful — all
for the better health of patients. McKesson has been named the “Most
Admired Company” in the healthcare wholesaler category by FORTUNE, a
Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly
company by Military Friendly. For more information, visit www.mckesson.com.